Search results

185 results

• NEWSROOM

  Dr. Falk Pharma acquires Kynos Therapeutics

  ...adding acute pancreatitis as a therapeutic focus and further strengthening its development portfolio
• NEWSROOM

  Following the footsteps of our founder

  Herbert Falk's granddaughter Elena decided to follow her grandpa's footsteps. Why? Find out more and follow Elena on her journey.
• NEWSROOM

  Dosing of the First United States Patient

  ...and expansion of the Phase 2b Study of Naronapride in Gastroparesis
• NEWSROOM

  In memory of our founder

  100 years ago today, Dr. Dr. Herbert Falk was born
• NEWSROOM

  Advancing the development of naronapride...

  ...for patients with PPI-non-responsive symptomatic GERD as the second naronapride indication
• NEWSROOM

  FDA clearance of IND application for naronapride

  ...to treat gastroparesis and subsequent expansion of ongoing phase 2b study to the US
• NEWSROOM

  New Addition to the Management Board

  The new Technical Operations business unit will be headed up by Dr. Andreas Rascher